Correlation Between AnaptysBio and Biomarin Pharmaceutical
Can any of the company-specific risk be diversified away by investing in both AnaptysBio and Biomarin Pharmaceutical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining AnaptysBio and Biomarin Pharmaceutical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between AnaptysBio and Biomarin Pharmaceutical, you can compare the effects of market volatilities on AnaptysBio and Biomarin Pharmaceutical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in AnaptysBio with a short position of Biomarin Pharmaceutical. Check out your portfolio center. Please also check ongoing floating volatility patterns of AnaptysBio and Biomarin Pharmaceutical.
Diversification Opportunities for AnaptysBio and Biomarin Pharmaceutical
0.63 | Correlation Coefficient |
Poor diversification
The 3 months correlation between AnaptysBio and Biomarin is 0.63. Overlapping area represents the amount of risk that can be diversified away by holding AnaptysBio and Biomarin Pharmaceutical in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Biomarin Pharmaceutical and AnaptysBio is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on AnaptysBio are associated (or correlated) with Biomarin Pharmaceutical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Biomarin Pharmaceutical has no effect on the direction of AnaptysBio i.e., AnaptysBio and Biomarin Pharmaceutical go up and down completely randomly.
Pair Corralation between AnaptysBio and Biomarin Pharmaceutical
Given the investment horizon of 90 days AnaptysBio is expected to under-perform the Biomarin Pharmaceutical. In addition to that, AnaptysBio is 4.94 times more volatile than Biomarin Pharmaceutical. It trades about -0.29 of its total potential returns per unit of risk. Biomarin Pharmaceutical is currently generating about -0.28 per unit of volatility. If you would invest 6,998 in Biomarin Pharmaceutical on August 24, 2024 and sell it today you would lose (653.00) from holding Biomarin Pharmaceutical or give up 9.33% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 95.65% |
| Values | Daily Returns |
AnaptysBio vs. Biomarin Pharmaceutical
Performance |
| Timeline |
| AnaptysBio |
| Biomarin Pharmaceutical |
AnaptysBio and Biomarin Pharmaceutical Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with AnaptysBio and Biomarin Pharmaceutical
The main advantage of trading using opposite AnaptysBio and Biomarin Pharmaceutical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if AnaptysBio position performs unexpectedly, Biomarin Pharmaceutical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biomarin Pharmaceutical will offset losses from the drop in Biomarin Pharmaceutical's long position.| AnaptysBio vs. Crinetics Pharmaceuticals | AnaptysBio vs. Rhythm Pharmaceuticals | AnaptysBio vs. Kura Oncology | AnaptysBio vs. CytomX Therapeutics |
| Biomarin Pharmaceutical vs. Alnylam Pharmaceuticals | Biomarin Pharmaceutical vs. Exelixis | Biomarin Pharmaceutical vs. Halozyme Therapeutics | Biomarin Pharmaceutical vs. Arrowhead Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Other Complementary Tools
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Stocks Directory Find actively traded stocks across global markets | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk |